supported by the National Key Research and Development Program of China(2022YFE0209700);Basic and Applied Basic Research Foundation of Guangzhou city(G23151013);Traditional Chinese Medicine Research Project of Guangdong Province(20241180);First-class Specialty Construction Project of Guangzhou Medical University(02-408-2304-13048XM);Discipline Construction Project of Guangzhou Medical University(02-445-2301192XM,02-445-2301223XM,02-445-2301191XM);Quality Project of Guangdong Province(01-408-2301064XM);Education Reform Project of Guangzhou Medical University(01-408-2301033XM);First-class Specialty Construction Project of Guangzhou Medical University(02-408-2304-13014XM);Research capacity improvement project of Guangzhou Medical University(02-410-2302365XM);Basic and Applied Basic Research Project of Guangzhou city(2023A04J0565).
Myocardial hypertrophy is a pathological thickening of the myocardium which ultimately results in heart failure. We previously reported that zonisamide, an antiepileptic drug, attenuated pressure overload-caused myoca...
This work was supported by Natural Science Foundation of Guangdong Province(2014A030313485);Scientific and Technological Planning Program of Guangzhou(2017071010458);Municipal Education Bureau Program of Guangzhou(1201610286);Natural Science Foundation of Guangdong Province(2018A030313719)。
Antiepileptic drug zonisamide has been shown to be curative for Parkinson’s disease(PD)through increasing HMG-CoA reductase degradation protein 1(Hrd1)level and mitigating endoplasmic reticulum(ER)stress.Hrd1 is an E...
supported by Natural Science Foundation of Guangdong Province(2014A030313485);Scientific and Technological Planning Program of Guangzhou(2017071010458);Municipal Education Bureau Program of Guangzhou(1201610286);Guangzhou Education Bureau(1201410365);Natural Science Foundation of Guangdong Province(2018A030313719).
Endoplasmic reticulum stress(ER stress)plays a key role in the development of cardiac hypertrophy and diabetic cardiomyopathy(DCM).Zonisamide(ZNS)was originally developed as an antiepileptic drug.Studies have shown th...
Zonisamide was kindly provided by Sumitomo Dainippon Pharma Co.,Ltd.,Japan;Studies conducted in the authors’ laboratory were supported by Grants-in-Aid from the MEXT,MHLW,and AMED of Japan
Drug repositioning is a strategy to identify a new application of a pre-approved drug,of which optimal dosage,administration routes,adverse effects,and contraindications are well established.Drug repositioning enables...
Zonisamide (ZNS), a commonly used anticonvulsant, scavenged hydroxyl radicals at a clinically relevant concentration. Reactants of ZNS with hydrogen peroxide and with hydrogen peroxide plus UV irradiation, yielding hy...